Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Chief Scientific Officer / Professor at eTheRNA immunotherapies NV / Vrije Universiteit Brussel
Kris Thielemans was trained as an MD at the Vrije Universiteit Brussel (VUB), spent some years in the Laboratory of Dr. R. Levy at the Department of Oncology at the Stanford University Medical School (Ca, USA) and obtained a PhD degree. Harnessing the immune system to combat cancer has been his major interest since then. He manages the Laboratory of Molecular and Cellular Therapy (LMCT) at the VUB for more than 30 years focusing on immune-therapeutic translational research and therapeutic vaccine development, including clinical trials for the treatment of cancer and HIV. He is founder and CSO of the spin-off company eTheRNA Immunotherapies NV to develop and implement mRNA based immunotherapy.